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Background: Biogenic hydrocarbons (biohydrocarbons) are broadly accepted to be the ideal ‘drop-in’ biofuel
alternative to petroleum-based fuels due to their highly similar chemical composition and physical characteristics.
The biological production of aliphatic hydrocarbons is largely dependent on engineering of the complicated
enzymatic network surrounding fatty acid biosynthesis.
Result: In this work, we developed a novel system for bioproduction of terminal fatty alkenes (1-alkenes) from
renewable and low-cost triacylglycerols (TAGs) based on the lipase hydrolysis coupled to the P450 catalyzed
decarboxylation. This artificial biosynthetic pathway was constituted using both cell-free systems including purified
enzymes or cell-free extracts, and cell-based systems including mixed resting cells or growing cells. The issues of high
cost of fatty acid feedstock and complicated biosynthesis network were addressed by replacement of the de novo
biosynthesized fatty acids with the fed cheap TAGs. This recombinant tandem enzymatic pathway consisting of the
Thermomyces lanuginosus lipase (Tll) and the P450 fatty acid decarboxylase OleTJE resulted in the production of
1-alkenes from purified TAGs or natural oils with 6.7 to 46.0% yields.
Conclusion: Since this novel hydrocarbon-producing pathway only requires two catalytically efficient enzymatic steps,
it may hold great potential for industrial application by fulfilling the large-scale and cost-effective conversion of
renewable TAGs into biohydrocarbons. This work highlights the power of designing and implementing an
artificial pathway for production of advanced biofuels.
Keywords: Lipase, P450 fatty acid decarboxylase, Alkenes, Cell-free catalysis, Whole cell catalysisIntroduction
Shortage of petroleum-based fuels and increasing environ-
mental concerns have led to great efforts to develop sus-
tainable and clean biofuels from renewable feedstocks.
Bioethanol manufactured by fermentation of sugars and
biodiesel produced via transesterification of vegetable oils,
animal fat, or waste oils are regarded as the two major
first-generation biofuels, which are dominating the
current global market of biofuels [1]. However, some* Correspondence: yjiny@126.com; lishengying@qibebt.ac.cn
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unless otherwise stated.undesirable properties such as high miscibility with
water and low energy density (for bioethanol), incom-
patibility with current engine systems, and problems
associated with storage and distribution have limited
their further popularization [2]. Therefore, advanced
biofuels with better fuel properties have been receiving
ever-increasing attention, among which biohydrocarbons,
especially the medium- to long-chain fatty alkanes/
alkenes, are considered the ideal alternatives to
petroleum-based transportation fuels due to their
highly similar chemical composition and physical char-
acteristics. Thus, biohydrocarbons hold the potential
to be developed into ‘drop-in’ biofuels compatible with
the existing distribution infrastructures used for gasoline,is is an Open Access article distributed under the terms of the Creative
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length [3].
At present, chemical hydrotreatment of acylglycerides,
fatty acids, or fatty acyl esters, and de novo microbial
biosynthesis are the two major strategies for production
of biohydrocarbons. The former strategy requires expen-
sive metal catalysts (for example, Pd and Pt), high
temperature (250 to 450°C), and high pressure (20 to
70 bar), hence being energy intensive and environmentally
unfriendly [4]. In comparison, the latter bioproduction
strategy highlighted by a limited number of metabolically
engineered systems is undoubtedly ‘greener’ [5-10].
However, all these biosynthetic systems suffer greatly
from low yield of hydrocarbons, preventing them from
industrialization.
For instance, the first engineered alkane biosynthetic
pathway consisting of the acyl-acyl carrier protein (ACP)
reductase Orf1594 from Synechococcus elongates PCC7942
and the aldehyde decarbonylase from Nostoc punctiforme
PCC73102 was constructed in Escherichia coli and gave rise
to a total alkane titer of approximately 300 mg/l [5]. Later,
two similar hybrid biosynthetic routes by coupling a car-
boxylic acid reductase or a fatty acid reductase complex to
the same fatty aldehyde decarbonylase were also reconsti-
tuted, however, leading to lower alkane yields [6,7]. Re-
cently, based on the in vivo activity of the long-chain fatty
acid P450 decarboxylase OleTJE, our laboratory engi-
neered a series of E. coli strains capable of de novo biosyn-
thesis of 1-alkenes from glucose with the highest total
alkene titer of 96.7 mg/l [10].
All these engineered pathways were constructed
through diverting the fatty acid biosynthetic pathway to-
ward hydrocarbon synthesis via different mechanisms of
deoxygenation (Figure 1A). Since fatty acid biosynthesis
plays a central role in energy metabolism of all living or-
ganisms and involves multiple interplaying enzymatic
steps [11-17], its regulation is highly complicated and
hence difficult to be manipulated. Metabolic engineer-
ing efforts aimed at overproduction of fatty acids or
their derivatives (for example, fatty acyl-ACPs or fatty
acyl CoAs) for high production of hydrocarbons via
genetically reprogramming the fatty acid biosynthetic
system turn out to be intrinsically difficult and technic-
ally challenging.
To overcome the limit of de novo biosynthesis of hy-
drocarbons, in this study, we propose a novel strategy
for long-chain fatty alkene biosynthesis through coupling
the glyceride hydrolytic activity of the Thermomyces
lanuginosus lipase (Tll) to the fatty acid decarboxylation
activity of the P450 enzyme OleTJE (Figure 1B). Tll has
been well characterized as a biocatalyst with remarkable
capacity of hydrolyzing triacylglycerols (TAGs) to free
fatty acids (FFAs) involved in oil modifications [18].
OleTJE was recently discovered as a novel P450 enzymewith the unique ability to decarboxylate long-chain FFAs,
forming terminal alkenes (1-alkenes) [19]. It is evident
that FFAs should be able to couple these two naturally un-
related reactions. Thus, we selected these two enzymes to
construct an artificial two-step biosynthetic pathway for
biological production of 1-alkenes.
In the pilot biosynthetic system based on purified en-
zymes, the exogenous feedstock including pure TAGs
and natural oils were first efficiently hydrolyzed by Tll,
and the released free fatty acids (FFAs) were decarboxy-
lated by OleTJE resulting in 1-alkenes (Graphical abstract
in Additional file 1). Upon the proof-of-concept by using
pure enzymes, the cell-based systems including the
mixed resting cells that express Tll and OleTJE, respect-
ively, and the resting cells that co-express Tll and OleTJE
were also evaluated. Moreover, the in situ catalytic sys-
tem that is capable of mediating the biotransformation
of TAGs→ FFAs→ 1-alkenes during cell growth was
further customized from the perspective of cost-effective
production of alkenes at industrial scale. This innovative
tandem biotransformation process for producing olefin
hydrocarbons from TAGs broadens the application of
lipase in biofuel synthesis, which has long been only
focused on biodiesel production [20-22]. The simple
two-step (hydrolysis followed by decarboxylation) enzym-
atic pathway appears to be efficient and more manageable
compared to the complex fatty acid biosynthetic network.
Since TAGs are widely present in plant oils, animal fats,
and oleaginous microbial cells [23], the feedstock for fu-
ture large-scale application of this new biohydrocarbon-
producing strategy should be abundant and cost-effective.
Results and discussion
Conversion of TAGs→ FFAs→ 1-alkenes catalyzed by
purified Tll and OleTJE
The two enzymes OleTJE and Tll were functionally
expressed in E. coli and purified to homogeneity (Figure
S1 in Additional file 2). In the lipase-catalyzed hydrolysis
of pure TAGs (0.5 mM) that only have C12, C14, and
C16 fatty acyl chains (that is, trilaurin, trimyristin, and
tripalmitin), Tll released 0.80 mM lauric acid (C12),
0.78 mM myristic acid (C14), and 1.15 mM palmitic
acid (C16), corresponding to 53.3 ± 1.3, 52.0 ± 1.1, and
76.7 ± 1.5% yield (Figure 2A), respectively.
To test whether the fatty acid decarboxylation activity
of OleTJE can be coupled to the lipase-catalyzed hydrolysis
in one pot, 2 μM OleTJE and 1 mM H2O2 as cofactor were
added into the TAG hydrolytic reactions. As expected,
0.35 mM 1-undecene (C11), 0.49 mM 1-tridecene (C13),
and 0.40 mM 1-pentadecene (C15) were produced
(Figure 2B), corresponding to 23.3 ± 0.9, 32.7 ± 1.4, and
26.7 ± 0.9% of the theoretically maximal conversion
from TAG to corresponding 1-alkene. When only tak-
ing the second decarboxylation step into account, as
Figure 1 Multi-step and artificial two-step pathways. (A) Native and engineered multi-step pathways for hydrocarbon biosynthesis based on
fatty acid metabolic network. (B) The artificial two-step 1-alkene biosynthetic pathway developed in this work consisting of the lipase Tll and the
P450 fatty acid decarboxylase OleTJE. AAR, acyl-ACP reductase; ACC, acetyl-CoA carboxylase; ACP, acyl carrier protein; ADC, aldehyde decarbonylase;
CAR, carboxylic acid reductase; FAR, fatty acid reductase; PDH, pyruvate dehydrogenase; TAG, triacylglycerol; TE, thioesterase.
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C16 FFA to corresponding 1-alkene were 39.8 ± 1.5,
58.3 ± 1.3, and 33.3 ± 1.1%, respectively. These results
evidently demonstrate the compatibility between the
reactions mediated by Tll and OleTJE. Among the
tested TAG hydrolysis reactions, Tll displayed the
highest activity toward tripalmitin (C16 TAG), which
indicates the fatty acyl chain length preference of Tll
being C16 over C14 and C12. By contrast, in the tandem
hydrolysis-decarboxylation process, the alkene product
with the greatest yield turned out to be 1-tridecene
(Figure 2B), decarboxylated from the C14 FFA-myristic
acid. In the one-pot catalytic relay, the consumption of
fatty acids by OleTJE (forming alkenes) was expected to
pull the equilibrium of TAGs ↔ fatty acids toward
fatty acids (Figure 1B). Consistently, the total FFA yield
of the tested dual enzymatic systems calculated by
summing up the reacted FFA (equals to the produced
alkene in mole) and the remaining FFA (Figure 2B) was
slightly improved compared to that of the single lipase
hydrolytic system (Figure 2A).
In a mixed biocatalytic system of dual enzymes, the ra-
tio between the two enzymes is often a key factor for the
overall conversion ratio. Thus, we elected to use trimyr-
istin (the TAG with three C14 fatty acyl chains), whichgave the highest 1-alkene yield at a 1:1 enzyme ratio
(Figure 2B), as substrate to optimize the proportion of
lipase to decarboxylase. As shown in Figure 2C, the C13
alkene yield was improved to 0.69 mM (corresponding
to 46.0 ± 1.8% conversion of TAG to alkene) at a molar
ratio of 1:2 (Tll:OleTJE). It was reported that the exten-
sive metabolic engineering efforts aimed at overproduc-
tion of FFAs in E. coli have so far achieved less than 30%
of the maximum theoretical yield via de novo biosyn-
thesis from the starting carbon source glucose [16]. The
reported yields of FFA downstream products such as hy-
drocarbons were even lower [5-7,10]. Thus, the 46.0%
overall conversion from TAG to 1-alkene achieved by
the cell-free system of tandem lipase-OleTJE in this work
appears significant. The in vitro manipulation via en-
zyme ratio optimization held another significant advan-
tage over the less accurate in vivo metabolic engineering,
which likely requires a delicate coordination of the com-
plicated regulation networks of transcription, translation,
and metabolite fluxes.
Subsequently, three natural oils other than pure TAGs
including olive oil, soybean oil, and microalgae oil were
investigated as substrates for the novel Tll-OleTJE cata-
lytic relay system. The Tll-catalyzed hydrolysis gave rise
to 1.21, 1.12, and 1.37 mM total FFAs from olive oil,
Figure 2 Production of FFAs and 1-alkenes and optimization of the enzyme ration between Tll and OleTJE. (A) Production of FFAs from
hydrolysis of different TAGs by purified Tll. (B) Production of FFAs and 1-alkenes from TAGs catalyzed by the coupled Tll-OleTJE. (C) Optimization
of the enzyme ratio between Tll and OleTJE for improvement of the overall alkene yield from the TAG with C14 fatty acyl chain length. (D)
Production of FFAs from hydrolysis of different natural oils by purified Tll. (E) Production of 1-alkenes from natural oils catalyzed by the
coupled Tll-OleTJE. (F) Production of 1-alkenes from microalgae oil mediated by purified enzymes and cell-free extracts. FFA, free fatty acid;
TAG, triacylglycerol.
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ing to 80.7 ± 2.3, 74.7 ± 2.1, and 91.3% ± 3.3 conversion
of TAGs to FFAs, respectively. The profiles of produced
FFAs are described in Table S1 in Additional file 3. In
the coupled hydrolysis-decarboxylation reactions, 0.34,
0.30, and 0.48 mM total alkenes including 1-tridecene
(for microalgae oil only), 1-pentadecene, and 1-heptadecene,
corresponding to 21.3 ± 0.7, 20.0 ± 0.9, and 32.0 ± 1.0 over-
all conversion from TAGs to alkenes (Figure 2E; Table S1
in Additional file 3), were produced from olive oil, soy-
bean oil, and microalgae oil, respectively. Interestingly, no
higher alkenes were observed in this coupled reaction sys-
tem, although FFAs of C20:5 and C22:6 were releasedfrom microalgae oil. This indicates the relatively lower
substrate flexibility of OleTJE than that of Tll, which is
consistent with the reported fatty acid chain length select-
ivity of saturated C12 to C20 [10,19]. Comparatively,
microalgae oil appeared to be a more suitable feedstock
for 1-alkene production via tandem biocatalysis. Since
microalgae oils could be an excellent feedstock for this
biosynthetic pathway to produce advanced hydrocarbon
biofuels, all following experiments used this feedstock.
To reduce the biocatalyst cost by omitting the enzyme
purification step, the crude E. coli cell-free extracts of Tll
and OleTJE were applied for the production of 1-alkene
using microalgae oil as feedstock. As a result, 0.39 mM
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yield when using purified enzymes (Figure 2F).
Production of 1-alkenes mediated by mixed resting E. coli
recombinant cells
Biotransformation mediated by whole cell catalysts rep-
resents a promising strategy for industrial manufacture
because it skips the costly enzyme purification and
immobilization steps. To reduce the cost on biocatalysts,
the two E. coli whole cell catalysts of Tll and OleTJE
were mixed and evaluated. Importantly, in the mixed cell
system, the enzyme ratio can be easily controlled by
adjusting cell dosage. However, multiple events of sub-
strate/product transfer across cell membrane must be
considered.
For the TAG hydrolytic reactions mediated by overex-
pressed cytoplasmic Tll in E. coli/pRSFDuet-tll whole
cells, freeze-dried cells hydrolyzed 70% microalgae oil to
form 1.05 mM FFAs (Figure 3A), which are more catalyt-
ically efficient than non-treated cells (0.9 mM, 60 ± 2.3%).
This indicates freeze-drying is a simple but effective way
to improve substrate accessibility and hence catalytic
activity.
To further improve mass transfer of TAG substrates,
Tll was periplasmically overexpressed in E. coli/pET-22Figure 3 Production of FFAs and 1-alkenes from microalgae oil and o
microalgae oil by resting E. coli cells with cytoplasmic and periplasmic over
lyzed by mixed resting E. coli cells. (C) Optimization of the enzyme ratio be
improvement of the overall alkene yield from microalgae oil.(b)-tll in order to hydrolyze TAGs more efficiently. As
expected, a higher yield of 80% (1.2 mM FFAs produced)
was achieved (Figure 3A). For periplasmic overexpres-
sion of Tll in E. coli, fusion of the Tll lipase to the pelB
leader sequence directs the lipase to E. coli periplasm,
where the leader peptide is removed by a signal peptidase
[24]. Considering that the two types of cells used for
biotransformations contained the same total activities
(normalized in terms of cell-free extract), we reason that
the enhancement of FFA production catalyzed by periplas-
mic Tll overexpression cells was likely attributed to im-
proved substrate accessibility by localization of enzymes in
periplasm. The freeze-dried E. coli/pET-22(b)-tll barely in-
creased the degree of hydrolysis (Figure 3A).
In the case of Tll-OleTJE coupled reaction in the
mixed cell system, E. coli/pET-22(b)-tll (for periplasmic
expression of Tll) plus E. coli/pACYCDuet-oleTJE (for
cytoplasmic expression of OleTJE) gave higher alkene
yield (0.21 mM, 14 ± 0.4%) than that (0.10 mM, 7 ± 0.3%)
of E. coli/pRSFDuet-tll (for cytoplasmic expression of Tll)
plus E. coli/pACYCDuet-oleTJE (for cytoplasmic expres-
sion of OleTJE) (Figure 3B). Also shown in Figure 3B, the
mixed freeze-dried cells displayed higher conversion than
the non-treated counterparts for the group with cyto-
plasmically overexpressed Tll (E. coli/pRSFDuet-tll + E.ptimization of enzyme ratio. (A) Production of FFAs from
expression of Tll. (B) Production of 1-alkenes from microalgae oil cata-
tween Tll and OleTJE in the form of freeze-dried whole cell catalysts for
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improvement for the group with periplasmic overex-
pression of Tll (E. coli/pET-22(b)-tll + E. coli/pACYC-
Duet-oleTJE).
Further optimization of the enzyme ratio in the form
of freeze-dried cells (E. coli/pET-22(b)-tll + E. coli/
pACYCDuet-oleTJE) enhanced the yield to 18 ± 0.8%
(0.27 mM) at a 1:2 molar ratio (Tll:OleTJE) (Figure 3C).
Although the ratio between the two enzymes can be ad-
justed in the mixed cell system, the catalytic efficiency of
the whole system apparently would suffer from compli-
cated transportation of intermediate FFAs from one type
of cells to another. This is likely the major reason for
the low conversions from TAGs to 1-alkenes. Therefore,
engineering of an E. coli strain with co-expression of the
two enzymes seems necessary.
Biosynthesis of 1-alkenes with a whole cell catalyst co-
expressing Tll and OleTJE
The approach of co-expressing Tll (for oil hydrolysis)
and OleTJE (for alkene formation) in the same E. coli host
could potentially overcome complex cross-membrane
transport of intermediate FFAs between different types of
cells, thereby gaining more efficient substrate channeling.
Thus, we constructed two types of co-expression strains
including E. coli/pRSFDuet-tll + pACYCDuet-oleTJE and
E. coli/pET-22(b)-tll + pACYCDuet-oleTJE and evaluated
their alkene-producing abilities. The non-treated E. coli
cells with cytoplasmic co-expression of Tll and OleTJE
(E. coli/pRSFDuet-tll + pACYCDuet-oleTJE) converted
11 ± 0.7% microalgae oil into 1-alkenes (0.16 mM),
whereas the freeze-dried cells gave a higher yield of 17 ±
1.1% (0.26 mM) (Figure 4A), both of which are greater
than that of corresponding mixed cell systems. This
improvement can be explained by better channeling of
intermediates between adjacent enzyme active sites
because of co-localization of two enzymes inside a
single cell.Figure 4 Production of 1-alkenes from microalgae oil. (A) Production o
co-expression of Tll and OleTJE. (B) Production of 1-alkenes from microalgaA similar profile was observed for the periplasmic
co-overexpression cell system (E. coli/pET-22(b)-tll +
pACYCDuet-oleTJE). Specifically, the strain of E. coli/
pET-22(b)-tll + pACYCDuet-oleTJE demonstrated improved
hydrocarbon yield (0.35 mM, 24 ± 1.3%) compared to
the corresponding cytoplasmic overexpression cell sys-
tem (E. coli/pRSFDuet-tll + pACYCDuet-oleTJE). Again,
this result indicates the importance of the contact be-
tween TAGs and Tll for the whole alkene-producing
pathway. The freeze-dried periplasmic overexpression
cells (E. coli/pET-22(b)-tll + pACYCDuet-oleTJE) did not
enhance the conversion (0.36 mM, 24 ± 1.4%) (Figure 4A),
indicating that freeze-drying treatment cannot further im-
prove the cell permeabilization that has already been opti-
mized by periplasmic expression of Tll. We infer that
periplasmic expression of Tll probably leads to better per-
meability than the corresponding cytoplasmic expression;
thus, the freeze-drying treatment showed a positive
permeabilization effect on the cytoplasmic co-expression
cell type, but not on the periplasmic co-expression type.
Measurement of the activity of the two enzymes con-
tained in co-expression cells showed molar ratios of
1:1.7 and 1:1.9 (Tll:OleTJE), respectively, close to the
optimal ratio of 1:2. More significantly, the periplasmic
co-expression cells retained more than 70 ± 3.2%
alkene-producing activity after recycling in three suc-
cessive batches, displaying great potential for industrial
application.
Biosynthesis of 1-alkenes by co-expressed Tll and OleTJE
in situ during cell growth
Integration of enzyme generation and enzymatic trans-
formation into a single process would be significantly
more energy efficient and of industrial simplification by
making better use of fermentation energy and skipping
enzyme purification. We previously developed an inte-
grated bioprocess for in situ biodiesel production that
occurs simultaneously with lipase generation in a Pichiaf 1-alkenes from microalgae oil catalyzed by E. coli resting cells with
e oil catalyzed by growing in situ E. coli cell catalysts.
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the present study, in parallel with combining hydrolysis
of TAGs and decarboxylation of FFAs into a single E.
coli host, we tested the strategy of developing E. coli in
situ catalytic system for biosynthesis of 1-alkenes from
TAGs. This in situ system integrated the process of en-
zyme production with the enzyme-catalyzed tandem bio-
transformations into a single process in one pot, which
could significantly save energy consumption and simplify
operational procedures.
Based on the tandem hydrolysis-decarboxylation in
situ catalyzed by Tll and OleTJE during cell growth, the
two types of Tll-OleTJE co-expression E. coli cells (E. coli/
pRSFDuet-tll + pACYCDuet-oleTJE and E. coli/pET-22(b)-
tll + pACYCDuet-oleTJE) gave 0.19 mM (12 ± 0.6%) and
0.46 mM (31 ± 1.1%) alkene yield from the fed microalgae
oils, respectively (Figure 4B). Interestingly, periplasmic
overexpression cells (E. coli/pET-22(b)-tll + pACYCDuet-
oleTJE) even secreted some lipases into the extracellular
space (that is, culture medium) during the in situ
process, which may significantly facilitate the hydrolysis-
decarboxylation coupled reactions, as reflected by enhanced
alkene production. Thus, the in situ catalytic system based
on periplasmic overexpression could take advantage of both
cell-free enzymes and whole cell catalysts. The extracellular
and intracellular enzymes of growing E. coli cells were likely
to be simultaneously utilized to produce alkenes in situ
and in one pot. Moreover, we further evaluated this in situ
system by recovering the whole cells and applied them for
a new batch reaction as resting whole cell catalysts, which
displayed 61.0 ± 2.2 and 73.0 ± 2.9% relative yield for
cytoplasmic overexpression cells (E. coli/pRSFDuet-tll +
pACYCDuet-oleTJE) and periplasmic overexpression cells
(E. coli/pET-22(b)-tll + pACYCDuet-oleTJE), respectively.
Notably, higher concentrations of the substrate oil (1
to 5 mM) or H2O2 (1 to 15 mM) were also tested; how-
ever, the alkene yields did not increase (data not shown).
It is possible that the low activity or low tolerance of
OleTJE toward the oil-FFA mixture may limit higher
alkene yield. Thus, based on the crystal structure of
OleTJE recently reported by Belcher et al. [26], the pro-
tein engineering of this enzyme to improve its activity or
tolerance in the context of two-step reactions could
be helpful for developing a more efficient converter
microorganism.
Compared to the in vivo construction and regulation
of metabolic pathways, the in vitro strategy of cell-free
enzyme-based and whole cell-based systems represents
an important opportunity for bioproduction of hydrocar-
bons. These in vitro systems could be readily controlled
through preparation of enzyme or whole cell cocktails
by simple mixing procedures or accurate modification of
reaction conditions [27,28]. These multiple cell-free en-
zyme systems (purified enzymes, cell-free extracts) andcell-based systems (mixed resting cells, whole cells with
co-expressed enzymes, growing in-situ cell catalysts)
provide more flexible choices for specific purpose and
situation (Figure 5).
Conclusion
A novel biosynthetic pathway for production of biohy-
drocarbon 1-alkenes from renewable oils was assembled,
which consists of the lipase Tll to release FFAs from
TAGs and the P450 fatty acid decarboxylase OleTJE
responsible for decarboxylation of FFAs to generate 1-
alkenes. The biotransformation of TAGs→ FFAs→ 1-al-
kenes was achieved using a variety of biocatalytic systems,
including purified enzymes, cell-free extracts, resting
whole cells, and growing in situ cell catalysts. These one-
pot tandem biocatalyzes only required two sequential
enzymatic steps, but allowed the efficient production of 1-
alkenes from TAGs with 6.7 to 46.0% conversion ratios
from 0.5 mM renewable feedstock including pure TAGs
and diverse natural oils. Especially, the biosynthesis of 1-
alkenes based on resting whole cells and growing in situ
cell catalysts exhibits potential for industrial application.
Finally, it is worth noting that this novel artificial bio-
synthetic route could be adapted for other microorgan-
isms, especially for those genetically tractable oleaginous
microorganisms if considering the abundant endogenous
TAGs as potential cellular substrates for the Tll-OleTJE
coupled system.
Materials and methods
Plasmids, strains, and reagents
The plasmids pACYCDuet-1, pRSFDuet-1, and pET-22
(b) were obtained from Novagen (Darmstadt, Germany).
Recombinant plasmid pET-28(b)-oleTJE for expression of
the P450 fatty acid decarboxylase OleTJE was con-
structed in our laboratory previously [10]. E. coli DH5α
and BL21 (DE3) strains were preserved in our labora-
tory. Various authentic standards of TAGs (C12, tri-
laurin, C14, trimyristin, and C16, tripalmitin), fatty acids
(lauric acid, myristic acid, palmitic acid, stearic acid, and
heptadecanoic acid), and fatty 1-alkenes (1-undecene,
1-tridecene, 1-pentadecene, and 1-heptadecene) were
purchased from TCI (Shanghai, China). Kanamycin,
chloramphenicol, thiamine, and isopropyl β-D-1-thio-
galactopyranoside (IPTG) were products of Solarbio
Science & Technology Co., Ltd (Beijing, China). All
used restricted enzymes were supplied by Thermo Scien-
tific (Shanghai, China). PrimeSTAR GXL DNA polymer-
ase and dNTPs were from Takara Bio Inc. (Otsu, Japan).
DNA manipulation kits were bought from Omega
Bio-Tek (Norcross, GA, USA) and Promega (Madison,
WI, USA). Ni-NTA resin was from Qiagen (Venlo,
Netherlands). PD-10 desalting columns were products of
GE Healthcare (Pewaukee, WI, USA). Ultra centrifugal
Figure 5 Catalytic systems for the conversion of triacylglycerol to 1-alkene. Various lipase-OleTJE coupling catalytic systems for the conversion of
triacylglycerol to 1-alkene including (A) purified enzymes, (B) cell-free extract, (C) mixed resting cells, (D) co-expression cells, and (E) in situ growing
cells. FFA, free fatty acid; TAG, triacylglycerol.
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USA). Bradford Protein Assay kit was bought from
Beyotime Institute of Biotechnology (Jiangsu, China).
Other routine reagents were commercially available
products of analytical grade. The tll gene was synthe-
sized by GenScript (Piscataway, NJ, USA). Oligo primers
were synthesized by Sangon Biotech (Shanghai, China).
Soybean oil and olive oil were purchased from local
market. Microalgae oil was kindly donated by Professor
Tianzhong Liu at the Qingdao Institute of Bioenergy and
Bioprocess Technology, Chinese Academy of Sciences.
TB medium was composed of 1.2% tryptone, 2.4%
yeast extract, 0.5% glycerol, 0.23% KH2PO4, and 1.25%
K2HPO4. One millimolar of thiamine was supplemented
for the expression of OleTJE. For maintaining correspond-
ing plasmids, 25 μg/ml chloramphenicol or 50 μg/ml
kanamycin was added.
The lysis buffer (pH 8.0) was composed of NaH2PO4
50 mM, NaCl 300 mM, glycerol 10%, amd imidazole
10 mM. The washing buffer (pH 8.0) comprised
NaH2PO4 50 mM, NaCl 300 mM, glycerol 10%, and
imidazole 20 mM. Elution buffer (pH 8.0) was composed
of NaH2PO4 50 mM, NaCl 300 mM, glycerol 10%, and
imidazole 250 mM. Desalting buffer (pH 7.4) was a mix-
ture of NaH2PO4, EDTA 1 mM, and glycerol 10%.
Cloning and expression of enzymes
The oleTJE gene was amplified using the previously con-
structed plasmid pET-28(b)-oleTJE as template and the
primer pair as follows: BamHI-oleTJE, CGCGGATCCG
ATGGCAACACTTAAGAGGGATAAGGGCTTA (the
BamHI restriction site is italicized); and HindIII-oleTJE,
CAATGAAGCTTTTATGTTCTGTCTAC AACTTCGC
(the italicized nucleotides denote the HindIII cutting
site). For tll gene cloning, the synthetic tll gene (Genbank
accession number AF054513.1) was used as template forPCR amplification with primers including BamHI-tll,
AGCCAGGATCCGAGTCCTATTCGTCGAGAGGTCT
CG and HindIII-tll, GCCGCAA GCTTCTAAAGACAT
GTCCCAATTAACCC. These amplified oleTJE and tll
fragments were double digested with BamHI/HindIII
and ligated into pACYCDuet-1 and pRSFDuet-1 to cre-
ate the recombinant plasmids pACYCDuet-oleTJE and
pRSFDuet-tll, respectively. The recombinant plasmids
were first transformed into competent cells of E. coli
DH5α for DNA sequence confirmation, and then trans-
formed into E. coli BL21 (DE3) for cytoplasmic overex-
pression of OleTJE and Tll. For construction of engineered
E. coli strains with periplasmic overexpression of lipase,
the plasmid pET-22(b) carrying an N-terminal pelB signal
sequence was used. The tll fragment from BamHI/HindIII
double digested pRSFDuet-tll was inserted into corre-
sponding sites of pET-22(b), resulting in the recombinant
plasmid pET-22(b)-tll. The engineered E. coli BL21 (DE3)
strains harboring corresponding recombinant plasmids
were similarly constructed as described above.
A single colony of the E. coli BL21 (DE3) strain carrying
pACYCDuet-oleTJE, pRSFDuet-tll, or pET-22(b) based
counterparts were used to inoculate the seed culture in
LB, and this culture was grown overnight at 37°C,
200 rpm. A 1% volume of pre-culture was inoculated into
1 l of TB medium with appropriate antibiotics (plus
0.5 mM 5-aminolevulinic acid and 1 mM thiamine for
OleTJE expression). When OD600 reached approximately
0.8, IPTG was added to the final concentration of 0.2 mM
for induction of enzyme expression at 18°C for 20 h.
Purification of enzymes
The harvested post-induced cells by centrifugation were
resuspended with 40 ml lysis buffer and disrupted using
ultra-sonication. Cell slurry was separated into cell-free
lysate and cell debris at 10,000 × g for 30 min at 4°C.
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50% Ni-NTA slurry at 4°C for 1 h. The mixture was
loaded onto a column and washed with 100 to 200 ml
washing buffer until no protein eluted in the flow-
through. The 6 × His tagged proteins bound to Ni-NTA
resin were eluted with 5 ml elution buffer. The eluted
protein fraction was concentrated using Millipore ultra-
filter with 30-kDa molecular weight cutoff (2,000 × g,
30 min, 4°C) and loaded onto a pre-equilibrated PD-10
column for buffer exchange using desalting buffer. All
protein fractions were monitored using Bradford Protein
Assay kit. The aliquots of collected fractions were flash
frozen by liquid nitrogen and stored at −80°C for later use.
Determination of enzyme concentration
Diluted purified OleTJE solution was reduced by adding
sodium dithionite prior to the initial scan at 400 to
600 nm to record the baseline spectrum. Then, the P450
enzyme solution was subjected to CO bubbling for 40 s
before the second scan to get the reduced CO-bound
P450 spectrum, based on which the functional OleTJE
was quantified from the absorbance difference between
A450 and A490 using the molar extinction coefficient of
91 mM−1 cm−1 [29]. The lipase activity was measured as
described elsewhere [25].
Whole cell catalyst preparation
The induced culture broth was centrifuged to harvest
fresh wet cells, termed as non-treated cells. These fresh
wet cells were subjected to freezing at −80°C for 12 h,
and then freeze-drying for 24 h with lyophilizer to ob-
tain freeze-dried cells.
Enzymatic assays and whole cell biotransformation
For cell-free enzyme biotransformation, the standard
100-μl hydrolysis reaction assay containing 0.5 mM sub-
strate, 2 μM purified Tll in sodium phosphate buffer
(100 mM, pH 7.4) was carried out in a 1.5-ml Eppendorf
tube at 30°C for 6 h. The tested substrates included pure
TAGs (fatty acyl chain length of C12, C14, and C16) and
oils (microalgae oil, soybean oil, and olive oil). For the
tandem reactions of hydrolysis followed by decarboxyl-
ation, 2 μM OleTJE and 1 mM H2O2 were supplemented
into the hydrolysis reaction while maintaining the total
volume of 100 μl. During optimization of the molar ratio
between these two enzymes, the amount of each enzyme
was adjusted appropriately.
For resting whole cell biotransformation, various
amounts of resting recombinant cells (approximate
50 mg) with the same activities (in terms of cell-free
extract) were added into 500 μl sodium phosphate buf-
fer containing 0.5 mM microalgae oil. In the case of
lipase-OleTJE coupled catalysis reaction, 1 mM H2O2
was supplied. During optimization of the enzyme ratio inthe whole cell catalysis, the cell amounts were accordingly
adjusted. In the whole cell-mediated recycling biotransfor-
mations, E. coli cells were recovered and washed after
each batch reaction, and then applied in a new batch reac-
tion. These resting whole cell-mediated biotransforma-
tions were performed at 30°C for 24 h.
For biotransformation mediated by growing cells in
situ, 12-h post-induction cultures were supplemented
with 0.5 mM microalgae oil and 1 mM H2O2 for
additional 36-h reaction in shaking flask at 28°C. All
experiments were repeated three times.
Determination of FFA and 1-alkene
The reactions were quenched and extracted with 100 μl
ethyl acetate containing 0.5 mM heptadecenoic acid as
internal standard for GC-MS analysis. The GC oven
equipped with the HP-INNOWAX (Agilent Technologies,
Inc., Santa Clara, CA, USA; 30 m× 0.25 mm× 0.25 μm)
column was heated using the program as follows: isother-
mal at 40°C for 4 min, 40 to 250°C at the rate of 10°C/min,
and 250°C for 15 min. The mass fragment range of 50 to
500 m/z was monitored under electron ionization con-
ditions (1741 eV). FFAs and alkenes were quantified
using corresponding standard compounds and the in-
ternal standard as references.
Additional files
Additional file 1: Graphical abstract. An artificial two-step biosynthetic
pathway for biological production of 1-alkenes using three kinds of
natural oils.
Additional file 2: Figure S1. Plasmid construction and purification of
Tll (A) and OleTJE (B).
Additional file 3: Table S1. Profiles of produced FFAs via lipase Tll
mediated hydrolysis and produced 1-alkenes via lipase-OleTJE tandem
biotransformation. All experiments were performed three times.
Abbreviations
TAGs: triacylglycerols; Tll: Thermomyces lanuginosus lipase; FFAs: free fatty
acids; IPTG: isopropyl β-D-1-thiogalactopyranoside.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JY and SL conceived of the study, designed the experiments, analyzed the
data, and wrote the manuscript. JY, YL, CW, and BH performed the
experiments. All authors read and approved the final manuscript.
Acknowledgements
This work was supported by the Qingdao Institute of Bioenergy and Bioprocess
Technology Director Innovation Foundation for Young Scientists (Grant
Number: Y37203410U), the Applied Basic Research Programs of Science and
Technology of Qingdao (Grant Number: 14-2-4-10-jch), the National Natural
Science Foundation of China (Grant Number: NSFC 31270855), and the National
High Technology Research and Development Program of China (Grant Number:
2014AA093510). We are also grateful for the funding from ‘Recruitment
Program of Global Experts, 2012.’ We thank Professor Tianzhong Liu at the
Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese
Academy of Sciences, for providing us with the microalgae oils.
Yan et al. Biotechnology for Biofuels  (2015) 8:34 Page 10 of 10Author details
1Key Laboratory of Biofuels, and Shandong Provincial Key Laboratory of
Energy Genetics, Qingdao Institute of Bioenergy and Bioprocess Technology,
Chinese Academy of Sciences, No. 189 Songling Road, 266101 Qingdao,
Shandong, China. 2University of Chinese Academy of Sciences, No. 19A
Yuquan Road, 100049 Beijing, China. 3Key Laboratory for Marine Drugs,
Department of Pharmacy, Renji Hospital, Shanghai Jiao Tong University
School of Medicine, No. 145 Shandongzhong Road, 200127 Shanghai, China.
Received: 16 September 2014 Accepted: 4 February 2015
References
1. Keasling JD, Chou H. Metabolic engineering delivers next-generation biofuels.
Nat Biotechnol. 2008;26:298–9.
2. Atsumi S, Liao JC. Metabolic engineering for advanced biofuels production
from Escherichia coli. Curr Opin Biotechnol. 2008;19:414–9.
3. Lee SK, Chou H, Ham TS, Lee TS, Keasling JD. Metabolic engineering of
microorganisms for biofuels production: from bugs to synthetic biology to
fuels. Curr Opin Biotechnol. 2008;19:556–63.
4. Serrano-Ruiz JC, Ramos-Fernández EV, Sepúlveda-Escribano A. From biodiesel
and bioethanol to liquid hydrocarbon fuels: new hydrotreating and advanced
microbial technologies. Energy Environ Sci. 2012;5:5638–52.
5. Schirmer A, Rude MA, Li X, Popova E, del Cardayre SB. Microbial
biosynthesis of alkanes. Science. 2010;329:559–62.
6. Akhtar MK, Turner NJ, Jones PR. Carboxylic acid reductase is a versatile
enzyme for the conversion of fatty acids into fuels and chemical
commodities. Proc Natl Acad Sci U S A. 2013;110:87–92.
7. Thomas PH, Sabine M, Karen M, Christoph E, Dagmara MK, George NT, et al.
Synthesis of customized petroleum-replica fuel molecules by targeted
modification of free fatty acid pools in Escherichia coli. Proc Natl Acad Sci
U S A. 2013;110:7636–41.
8. Beller HR, Goh EB, Keasling JD. Genes involved in long-chain alkene biosynthesis
in Micrococcus luteus. Appl Environ Microbiol. 2010;76:1212–23.
9. Sukovich DJ, Seffernick JL, Richman JE, Gralnick JA, Wackett LP. Widespread
head-to-head hydrocarbon biosynthesis in bacteria and role of OleA. Appl
Environ Microbiol. 2010;76:3850–62.
10. Liu Y, Wang C, Yan JY, Zhang W, Guan WN, Lu XF, et al. Hydrogen
peroxide-independent production of α-alkenes by OleTJE P450 fatty acid
decarboxylase. Biotechnol Biofuels. 2014;7:28–39.
11. Kung Y, Runguphan W, Keasling JD. From fields to fuels: recent advances in
the microbial production of biofuels. ACS Synth Biol. 2012;1:498–513.
12. Peralta-Yahya PP, Zhang FZ, del Cardayre SB, Keasling JD. Microbial
engineering for the production of advanced biofuels. Nature. 2012;488:320–8.
13. Steen EJ, Kang Y, Bokinsky G, Hu Z, Schirmer A, McClure A, et al. Microbial
production of fatty-acid-derived fuels and chemicals from plant biomass.
Nature. 2010;463:559–62.
14. Liu TG, Vora H, Khosla C. Quantitative analysis and engineering of fatty acid
biosynthesis in E. coli. Metab Eng. 2010;12:378–86.
15. Lu XF, Vora H, Khosla C. Overproduction of free fatty acids in E. coli:
implications for biodiesel production. Metab Eng. 2008;10:333–9.
16. Lennen RM, Pfleger BF. Engineering Escherichia coli to synthesize free fatty
acids. Trends Biotechnol. 2012;30:659–67.
17. Lennen RM, Max AK, Kritika K, Robert AZ, Kristin EB, Mary SL, et al.
Membrane stresses induced by overproduction of free fatty acids in
Escherichia coli. Appl Environ Microbiol. 2011;77:8114–28.
18. Fernandez-Lafuente R. Lipase from Thermomyces lanuginosus: uses and
prospects as an industrial biocatalyst. J Mol Catal B Enzym. 2010;62:197–212.
19. Rude MA, Baron TS, Brubaker S, Alibhai M, del Cardayre SB, Schirmer A. Terminal
olefin (1-alkene) biosynthesis by a novel P450 fatty acid decarboxylase from
Jeotgalicoccus species. Appl Environ Microbiol. 2011;77:1718–27.
20. Yan JY, Yan YJ, Liu SX, Hu J, Wang GL. Preparation of cross-linked lipase-coated
micro-crystals for biodiesel production from waste cooking oil. Bioresour
Technol. 2011;102:4755–8.
21. Yan JY, Li AT, Xu Y, Ngo Thao PN, Phua SC, Li Z. Efficient production of
biodiesel from waste grease: one-pot esterification and transesterification
with tandem lipases. Bioresour Technol. 2012;123:332–7.
22. Yan JY, Zheng XL, Li SY. A novel and robust recombinant Pichia pastoris
yeast whole cell biocatalyst with intracellular overexpression of a
Thermomyces lanuginosus lipase: preparation, characterization and
application in biodiesel production. Bioresour Technol. 2014;151:43–8.23. Luisa G, Ana CO. Microalgae as a raw material for biofuels production. J Ind
Microbiol Biotechnol. 2009;36:269–74.
24. Brundiek HB, Evitt AS, Kourist R, Bornscheuer UT. Creation of a lipase highly
selective for trans fatty acids by protein engineering. Angew Chem Int Ed.
2012;51:412–4.
25. Yan JY, Zheng XL, Du L, Li SY. Integrated lipase production and in situ
biodiesel synthesis in a recombinant Pichia pastoris yeast: an efficient dual
biocatalytic system composed of cell free enzymes and whole cell catalysts.
Biotechnol Biofuels. 2014;7:55–62.
26. Belcher J, McLean KJ, Matthews S, Woodward LS, Fisher K, Rigby SE, et al.
Structure and biochemical properties of the alkene producing cytochrome
P450 OleTJE (CYP152L1) from the Jeotgalicoccus sp. 8456 bacterium. J Biol
Chem. 2014;289:6535–50.
27. You C, Zhang YHP. Self-assembly of synthetic metabolons through synthetic
protein scaffolds: one-step purification, co-immobilization, and substrate
channeling. ACS Synth Biol. 2013;2:102–10.
28. Zhang YHP, Sun JB, Zhong JJ. Biofuel production by in vitro synthetic
enzymatic pathway biotransformation. Curr Opin Biotechnol. 2010;21:663–9.
29. Johnston WA, Huang WL, De Voss JJ, Hayes MA, Gillam EMJ. Quantitative
whole-cell cytochrome P450 measurement suitable for high-throughput
application. J Biomol Screen. 2008;13:135–41.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
